At IMGM, we use the oligonucleotide array-CGH platform developed by Agilent Technologies. This cutting-edge platform enables us to provide you with high resolution whole-genome screening data for genomic aberrations. Zoom-in custom arrays can be designed for a more detailed analysis of your genomic region of interest.
Alternatively, IMGM also offers array-CGH screening service based on BlueGnome’s CytoChip™. This service is carried out in collaboration with our strategic partner “Center for human genetics and laboratory medicine, Dr. Klein & Dr. Rost” in Martinsried.
To validate your array-CGH-based copy number findings, IMGM offers a complementary real-time PCR-based CNV validation service. For more information on this service, please click here.
For a detailed description of this service, please download the PDF-document: IMGM Services Flyer - Copy number variation (CNV)